Krystal Biotech (KRYS) Research & Development (2016 - 2026)
Krystal Biotech's Research & Development was $14.52 million in Q2 2026, up 0.7% from $14.41 million a year earlier but down 5.3% from the prior quarter.
Powered by 
Analysis
Krystal Biotech (KRYS) Research & Development (2016 - 2026) Analysis & Trends
On a trailing twelve-month basis, Krystal Biotech's Research & Development was $59.23 million through Jun 30, 2026, up 6.3% year-over-year; for FY2025, it was $58.05 million, up 8.3% from FY2024.
- Research & Development has now increased for nine consecutive years, with a five-year compound annual growth rate of 26.5% (FY2020 to FY2025).
- In earlier years, Research & Development was $53.58 million in FY2024 (+15.4%), $46.43 million in FY2023 (+9.4%), $42.46 million in FY2022 (+52.3%) and $27.88 million in FY2021 (+55.5%).
- Quarterly Research & Development has moved between $6.08 million (Q3 2021) and $15.58 million (Q2 2024) over five years.
- Compared with a year earlier, Research & Development has increased for four straight quarters, with growth averaging 11.8% over the last eight quarters.
- The best year-over-year quarter for Research & Development over five years was Q3 2022 (growth of 89.4%); the worst was Q1 2024 (a decline of 10.8%).
- Per Business Quant data, KRYS's Research & Development in the three quarters before Q2 2026 was $15.33 million (Q1 2026), $14.79 million (Q4 2025) and $14.59 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 3.65 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 2.34 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 9.74 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | -2.85 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | -4.05 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 1.87 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 1.76 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 2.81 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 993.80 Mn |
| 10 | Krystal Biotech | 9.98 Bn | 6.75 Bn | 112.79 Mn | 14.52 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 14.52 Mn |
| Mar 31, 2026 | 15.33 Mn |
| Dec 31, 2025 | 14.79 Mn |
| Sep 30, 2025 | 14.59 Mn |
| Jun 30, 2025 | 14.41 Mn |
| Mar 31, 2025 | 14.26 Mn |
| Dec 31, 2024 | 13.53 Mn |
| Sep 30, 2024 | 13.51 Mn |
| Jun 30, 2024 | 15.58 Mn |
| Mar 31, 2024 | 10.96 Mn |
| Dec 31, 2023 | 11.37 Mn |
| Sep 30, 2023 | 10.63 Mn |
| Jun 30, 2023 | 12.14 Mn |
| Mar 31, 2023 | 12.29 Mn |
| Dec 31, 2022 | 10.74 Mn |
| Sep 30, 2022 | 11.52 Mn |
| Jun 30, 2022 | 10.89 Mn |
| Mar 31, 2022 | 9.31 Mn |
| Dec 31, 2021 | 9.01 Mn |
| Sep 30, 2021 | 6.08 Mn |
API Access
Krystal Biotech Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=KRYS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "KRYS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=KRYS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();